Top 5 Casino Stocks To Watch For 2023

If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).

Source: Tada Images /

DraftKings began as a fantasy sports game manager. It took advantage of the 2018 Supreme Court decision allowing the legalization of sports gambling to build an empire.

On August 12 that empire was worth $21 billion. The stock opened for trade at about $52.20 per share. Caesar’s Entertainment (NYSE:CZR), the largest physical casino operator, is worth $19.8 billion. Caesar’s had revenue of $2.5 billion in the June quarter, DraftKings about $300 million. 

Top 5 Casino Stocks To Watch For 2023: Tile Shop Hldgs, Inc.(TTS)

Tile Shop Holdings, Inc. operates as a specialty retailer of manufactured and natural stone tiles, setting and maintenance materials, and related accessories in the United States. It offers approximately 4,000 products, including ceramic, porcelain, glass, and metal tiles; and marble, granite, quartz, sandstone, travertine, slate, and onyx tiles primarily under the Rush River and Fired Earth brand names. The company also manufactures setting and maintenance materials, such as thinset, grout, and sealers under the Superior brand name. As of April 19, 2016, it operated 116 stores in 31 states with an average size of 21,700 square feet. The company also sells its products through its Website, Tile Shop Holdings, Inc. was founded in 1985 and is headquartered in Plymouth, Minnesota.

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Internet Gold Golden Lines (NASDAQ:IGLD) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Internet Gold Golden Lines earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 47.7616640405736 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 5 Casino Stocks To Watch For 2023: Bumble Inc.(BMBL)

Bumble Inc. provides online dating and social networking platforms in North America, Europe, internationally. It owns and operates websites and applications that offers subscription and credit-based dating products. The company operates two apps, Bumble and Badoo with approximately 40 million users on monthly basis. Bumble Inc. was founded in 2014 in and is headquartered in Austin, Texas.

Advisors’ Opinion:

  • [By ]

    However, traditional IPOs have had quite the year too, including the debuts of well-known names such as Weber (WEBR), Bumble (BMBL) and Duolingo (DUOL).

  • [By Manali Bhade (tmfmanab)]

    What is common between leading chipmaker Advanced Micro Devices (NASDAQ:AMD) and women-first online dating player Bumble (NASDAQ:BMBL)? While there are no obvious similarities as far as the business models are concerned, both companies enjoy solid competitive advantages in their respective markets and are growing their top line at impressive rates. These are exactly the kind of business fundamentals investors should be considering while building a long-term portfolio.

  • [By Leo Sun (TMFSunLion)]

    Bumble’s (NASDAQ:BMBL) stock price rallied on Aug. 12 after the online dating company posted its second-quarter numbers. Investors seemed to like what they saw in the report. But is the stock worth buying after that post-earnings pop?

Top 5 Casino Stocks To Watch For 2023: Chatham Lodging Trust (REIT)(CLDT)

Chatham Lodging Trust, incorporated on October 26, 2009, is a real estate investment trust (REIT) organized to invest primarily in premium-branded upscale extended-stay and select-service hotels. All of the Company’s assets are held by, and all of its operations are conducted through, Chatham Lodging, L.P (Operating Partnership). The Operating Partnership and its subsidiaries lease the Company’s hotels. The Company owns approximately 40 hotels with over 5,680 (unaudited) rooms located in 15 states in the United States and the District of Columbia.

The Company’s hotels include upscale extended-stay hotels that operate under the Residence Inn by Marriott brand (over 10 hotels) and Homewood Suites by Hilton brand (approximately nine hotels), as well as premium-branded select-service hotels that operate under the Courtyard by Marriott brand (over four hotels), the Hampton Inn or Hampton Inn and Suites by Hilton brand (over three hotels), the SpringHill Suites by Marriott brand (approximately two hotels), the Hilton Garden Inn by Hilton brand (over two hotels) and the Hyatt Place brand (approximately two hotels). The service and amenity offerings of a few of these hotels include complimentary breakfast, Internet access, local calls, in-room movie channels, and daily linen and room cleaning service. Its hotels are located in Billerica, Massachusetts; Bloomington, Minnesota; Brentwood, Tennessee; Dallas, Texas; Farmington, Connecticut; Maitland, Florida; Houston, Texas; Altoona, Pennsylvania; Washington, Pennsylvania; Holtsville, New York; Garden Grove, California; Exeter, New Hampshire; Denver, Colorado; Savannah, Georgia, and Vienna, Virginia, among others.

Advisors’ Opinion:

  • [By Shane Hupp]

    TheStreet cut shares of Chatham Lodging Trust (NYSE:CLDT) from a b rating to a c+ rating in a research report report published on Thursday morning.

  • [By Motley Fool Transcribers]

    Chatham Lodging Trust  (NYSE:CLDT)Q4 2018 Earnings Conference CallFeb. 25, 2019, 10:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Casino Stocks To Watch For 2023: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Leave a Reply

Your email address will not be published.